Skip to main content

Table 3 Quality appraisal of CPGs for depression in adults, using the AGREE-II instrument

From: Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review

CPG (code)

AGREE-II domains

Quality of the systematic reviews (Yes or No)

1

2

3

4

5

6

7

Overall assessment

Mentions databases used

Mentions search strategy

List of included studies is available

Mentioned risk of bias assessment as part of their methodology

Canadian Network for Mood and Anxiety Treatments (CANMAT)

92%

67%

53%

83%

0%

100%

67%

66%

Yes

Yes

No

No

Depression Guideline Development Group (WHO)

100%

67%

48%

89%

38%

8%

50%

57%

Yes

No

No

No

National Collaborating Centre for Mental Health, National Institute for Health and Clinical Excellence (NICE)

100%

100%

85%

100%

40%

100%

83%

87%

Yes

Yes

Yes

Yes

Agencia de Evaluación de Tecnologías Sanitarias de Galicia (GuiaSalud)

100%

92%

60%

94%

96%

100%

67%

87%

Yes

No

Yes

Yes

American College of Physicians (ACP)

100%

89%

88%

72%

0%

100%

83%

76%

Yes

Yes

Yes

Yes

American Psychiatric Association (APA)

94%

64%

55%

89%

15%

100%

67%

67%

Yes

No

No

No

Royal Australian and New Zealand

College of Psychiatrists (RANZCP)

100%

81%

59%

100%

8%

100%

67%

74%

Yes

No

No

No

US Preventive Services Task Force Recommendation Statement (USTF)

94%

53%

65%

86%

17%

100%

83%

71%

Yes

Yes

Yes

Yes

Management of Major Depressive Disorder Working Group (VADoD)

94%

86%

78%

100%

17%

100%

83%

80%

Yes

Yes

No

Yes

Korean Guideline Development Team for Depression (Korea)

75%

47%

45%

78%

4%

83%

42%

53%

Yes

No

No

No

British Association for Psychopharmacology (BAP)

83%

56%

55%

78%

13%

83%

58%

61%

Yes

No

No

Yes

  1. Find in boldface values above 70% which represents adequate quality